Medicare and Medicaid Programs: Application From the Center for Improvement in Healthcare Quality for Continued Approval of Its Hospital Accreditation Program, 77615-77617 [2022-27465]
Download as PDF
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
with the FAR provision 52.225–18,
Place of Manufacture. This provision
requires offerors of manufactured end
products to indicate in response to a
solicitation, by checking a box, whether
the place of manufacture of the end
products it expects to provide is
predominantly manufactured in the
United States or outside the United
States. Contracting officers use the
information as the basis for entry into
the Federal Procurement Data System
for further data on the rationale for
purchasing foreign manufactured items.
The data is necessary for analysis of the
application of the Buy American statute
and the trade agreements.
C. Annual Burden
Respondents: 50,106.
Total Annual Responses: 2,600,361.
Total Burden Hours: 26,004.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0161, Reporting
Purchases from Sources Outside the
United States, in all correspondence.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–27430 Filed 12–16–22; 8:45 am]
[FR Doc. 2022–27454 Filed 12–16–22; 8:45 am]
BILLING CODE 6820–EP–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention
[CMS–3429–FN]
Notice of Closed Meeting
tkelley on DSK125TN23PROD with NOTICE
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–OH–22–002, NIOSH Centers for
Agricultural Safety and Health.
Date: March 7, 2023.
Time: 11:00 a.m.–6:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Officer, Office of
Extramural Programs, National Institute
for Occupational Safety and Health,
CDC, 1095 Willowdale Road,
Morgantown, West Virginia, 26505;
Telephone: (304) 285–5879; Email:
MRidenour@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
Medicare and Medicaid Programs:
Application From the Center for
Improvement in Healthcare Quality for
Continued Approval of Its Hospital
Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces our
decision to approve the Center for
Improvement in Healthcare Quality
(CIHQ) for continued recognition as a
national accrediting organization for
hospitals that wish to participate in the
Medicare or Medicaid programs.
DATES: The decision announced in this
notice is applicable January 1, 2023
through January 1, 2028.
FOR FURTHER INFORMATION CONTACT:
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
77615
Erin Imhoff, (410) 786–2337.
Caecilia Blondiaux, (410) 786–2190.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a hospital, provided
certain requirements are met. Section
1861(e) of the Social Security Act (the
Act) establishes statutory authority for
the Secretary of the Department of
Health and Human Services (Secretary)
to set distinct criteria for facilities
seeking designation as a hospital.
Regulations concerning provider
agreements are at 42 CFR part 489 and
those pertaining to activities relating to
the survey and certification of facilities
are at 42 CFR part 488. The regulations
at 42 CFR part 482 specify the minimum
conditions of participation that a
hospital must meet to participate in the
Medicare program.
Generally, to enter into an agreement,
a hospital must first be certified by a
state survey agency (SA) as complying
with the conditions or requirements set
forth in part 482 of our regulations.
Thereafter, the hospital is subject to
regular surveys by a SA to determine
whether it continues to meet these
requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)
approved national accrediting
organization (AO) that all applicable
Medicare requirements are met or
exceeded, we will deem those provider
entities as having met such
requirements. Accreditation by an AO is
voluntary and is not required for
Medicare participation.
If an AO is recognized by the
Secretary of the Department of Health
and Human Services (the Secretary) as
having standards for accreditation that
meet or exceed Medicare requirements,
any provider entity accredited by the
national accrediting body’s approved
program would be deemed to meet the
Medicare requirements. A national AO
applying for approval of its
accreditation program under part 488,
subpart A, must provide CMS with
reasonable assurance that the AO
requires the accredited provider entities
to meet requirements that are at least as
stringent as the Medicare requirements.
Our regulations concerning the approval
of AOs are set forth at §§ 488.4, 488.5
and 488.5(e)(2)(i). The regulations at
§ 488.5(e)(2)(i) require AOs to reapply
for continued approval of its
accreditation program every 6 years or
sooner, as determined by CMS.
E:\FR\FM\19DEN1.SGM
19DEN1
77616
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
Center for Improvement in Healthcare
Quality (CIHQ)’s current term of
approval for their hospital accreditation
program expires July 26, 2023. As
discussed in the proposed notice (87 FR
43525), CIHQ submitted its application
for renewal earlier than expected and
therefore CMS will adjust their future
term of approval accordingly.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMS
approval of an accreditation program is
conducted in a timely manner. The Act
provides us 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, we must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
of the 210-day period, we must publish
a notice in the Federal Register
approving or denying the application.
tkelley on DSK125TN23PROD with NOTICE
III. Provisions of the Proposed Notice
On July 21, 2022, we published a
proposed notice in the Federal Register
(87 FR 43525), announcing CIHQ’s
request for continued approval of its
Medicare hospital accreditation
program. In that proposed notice, we
detailed our evaluation criteria. Under
section 1865(a)(2) of the Act and in our
regulations at §§ 488.5 and 488.8(h), we
conducted a review of CIHQ’s Medicare
hospital accreditation application in
accordance with the criteria specified by
our regulations, which include, but are
not limited to the following:
• An administrative review of
CIHQ’s: (1) corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its CIHQ facility
surveyors; (4) ability to investigate and
respond appropriately to complaints
against accredited CIHQ facilities; and
(5) survey review and decision-making
process for accreditation.
• A review of CIHQ’s survey
processes to confirm that a provider or
supplier, under CIHQ’s hospital
deeming accreditation program, meets
or exceeds the Medicare program
requirements.
• A documentation review of CIHQ’s
survey process to do the following:
++ Determine the composition of the
survey team, surveyor qualifications,
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
and CIHQ’s ability to provide
continuing surveyor training.
++ Compare CIHQ’s processes to
those we require of state survey
agencies, including periodic resurvey
and the ability to investigate and
respond appropriately to complaints
against CIHQ accredited hospitals.
++ Evaluate CIHQ’s procedures for
monitoring accredited hospitals it has
found to be out of compliance with its
program requirements.
++ Assess CIHQ’s ability to report
deficiencies to the surveyed hospitals
and respond to the hospitals plan of
correction in a timely manner.
++ Determine the adequacy of CIHQ’s
staff and other resources.
++ Confirm CIHQ’s ability to provide
adequate funding for performing
required surveys.
++ Confirm CIHQ’s policies with
respect to surveys being unannounced.
++ Confirm CIHQ’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain CIHQ’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
IV. Analysis of and Responses to Public
Comments on the Proposed Notice
In accordance with section
1865(a)(3)(A) of the Act, the July 21,
2022 proposed notice also solicited
public comments regarding whether
CIHQ’s requirements met or exceeded
the Medicare conditions of participation
for hospitals. We received
approximately 19 timely public
comments from hospitals and
individuals, and another that was out of
scope of the proposed rule.
Comment: Most commenters
expressed support for CIHQ and their
hospital accreditation program and
encouraged CMS to approve them for
continued recognition as a national AO
for hospitals.
Response: We appreciate the support
from those hospitals who have
experience with CIHQ’s Medicare
hospital accreditation program and
agree that CIHQ should be approved for
continued recognition as a national AO
for hospitals that wish to participate in
the Medicare or Medicaid programs.
Comment: A commenter expressed
concern about hospital accreditation
programs overall and the responsibility
of CMS to oversee the process. The
comment was not specific to CIHQ.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Response: We appreciate this
comment and the concern for patient
safety and quality of care. We continue
to prioritize patient safety and our
responsibility for oversight of AOs. As
described in section III. Provisions of
the Proposed Notice of this notice, CMS
takes various steps when considering
whether to approve or not approve a
national AO. Each AO wishing to be
recognized by Medicare as a national
AO must go through a rigorous process
for CMS approval. We remain steadfast
in our commitment to keeping the
public informed of our evaluation
process for AOs seeking approval from
CMS.
Comment: A commenter expressed
concern for paying out of pocket for
chronic diseases.
Response: We thank the commenter
for expressing concern, but this
comment is outside the scope of the
notice.
Final Decision: After consideration of
the public comments received, we are
finalizing our decision to approve
CIHQ’s application for continued
recognition as a national AO for
hospitals that wish to participate in the
Medicare or Medicaid programs.
V. Provisions of the Final Notice
A. Differences Between CIHQ’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared CIHQ’s hospital
accreditation requirements and survey
process with the Medicare conditions of
participation of part 482, and the survey
and certification process requirements
of parts 488 and 489. Our review and
evaluation of CIHQ’s renewal
application, which were conducted as
described in section III. of this final
notice, yielded the following areas
where, as of the date of this notice,
CIHQ has completed revising its
standards and certification processes in
order to—
• Meet the requirements of all of the
following Medicare regulations:
++ Section 482.41(a)(1), to include
the appropriate Life Safety Code (LSC)
references that address hospitals
classified as new occupancies.
++ Section 482.41(b)(1)(i), to include
the appropriate National Fire Protection
Agency (NFPA) 101 requirements for
hospitals classified as Business
Occupancies.
++ Section 482.41(d)(4), to include
compliance with the 2008 American
Society of Heating, Refrigerating and
Air-Conditioning Engineers (ASHRAE)
Standard 170—Ventilation of Health
Care Facilities, in accordance with 2012
E:\FR\FM\19DEN1.SGM
19DEN1
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
tkelley on DSK125TN23PROD with NOTICE
NFPA requirements and to ensure
sterile supply and medical equipment
manufacturer instructions for use (IFUs)
are considered before hospitals reduce
relative humidity levels.
++ Section 488.5(a)(3), to correct
formatting and technical errors in the
crosswalk as requested by CMS.
In addition to the standards review,
CMS reviewed CIHQ’s comparable
survey processes, which was conducted
as described in section III. of this notice,
and also reviewed corporate policies,
which yielded the following areas
where, as of the date of this notice,
CIHQ has completed revising its survey
processes to demonstrate that it uses
survey processes that are comparable to
state survey agency processes by:
++ Revising Facility & Life Safety
worksheets for surveyors to explain that
the worksheet does not include all 2012
LSC & Health Care Facilities Code
requirements in accordance with survey
comparability at § 488.5(a)(4)(ii).
++ Providing additional training to
surveyors related to the number of
medical records that should be reviewed
during the survey of larger hospitals in
accordance with survey comparability at
§ 488.5(a)(4)(ii).
++ Improving the level of detail in
survey documentation in accordance
with survey comparability at
§ 488.5(a)(4)(ii).
++ Providing CMS with the job
description required for CIHQ’s LSC
Consultants in accordance with the
description of education and experience
requirements surveyors must meet at
§ 488.5(a)(7).
++ Revising complaint procedures to
ensure the survey investigation process
is clearly documented in accordance
with the organizations complaint
procedures at § 488.5(a)(12).
B. Term of Approval
Based on our review and observations
described in section III. and section V.
of this notice, we approve CIHQ as a
national accreditation organization for
hospitals that request participation in
the Medicare program. The decision
announced in this notice is effective
January 1, 2023 through January 1, 2028
(5 years). Due to the timing of the start
of the fiscal year and associated travel
restrictions, CMS was unable to conduct
a hospital survey observation of CIHQ
surveyors in accordance with 42 CFR
488.8(h), which is one component of the
comparability evaluation. Therefore, we
are providing CIHQ with a reduced term
of approval. In accordance with 42 CFR
488.5(e)(2)(i), CMS may not give a term
of the approval that exceeds 6 years.
Based on our discussions with CIHQ
and the information provided in its
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
application, we are confident that CIHQ
will continue to ensure that its deemed
hospitals will continue to meet or
exceed Medicare standards.
Additionally, CIHQ has applied for
critical access hospital deeming
authority and as part of that application
we will complete a survey observation.
Critical access hospitals have similar
CoPs and survey process to hospitals
and therefore we are confident in a 5year approval term for this application.
VI. Collection of Information and
Regulatory Impact Statement
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: December 14, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2022–27465 Filed 12–16–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–N–2810]
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting; Establishment of a Public
Docket; Request for Comments
Food and Drug Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice; establishment of a
public docket; request for comments.
AGENCY:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Vaccines and Related
Biological Products Advisory
Committee (VRBPAC). The general
function of the committee is to provide
advice and recommendations to FDA on
regulatory issues. On January 26, 2023,
the committee will meet in open session
to discuss the future vaccination
SUMMARY:
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
77617
regimens addressing COVID–19. The
meeting will be open to the public. FDA
is establishing a docket for public
comment on this document.
DATES: The meeting will be held
virtually on January 26, 2023, from 8:30
a.m. to 5:30 p.m. Eastern Time.
ADDRESSES: Please note that due to the
impact of this COVID–19 pandemic, all
meeting participants will be joining this
advisory committee meeting via an
online teleconferencing platform.
Answers to commonly asked questions
about FDA advisory committee
meetings, including information
regarding special accommodations due
to a disability, may be accessed at:
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm. The online web
conference meeting will be available at
the following link on the day of the
meeting: https://youtu.be/
ZjULNuSYfd0.
FDA is establishing a docket for
public comment on this meeting. The
docket number is FDA–2022–N–2810.
Please note that late, untimely filed
comments will not be considered. The
docket will close on January 25, 2023.
Either electronic or written comments
on this public meeting must be
submitted by January 25, 2023. The
https://www.regulations.gov electronic
filing system will accept comments
until 11:59 p.m. Eastern Time at the end
of January 25, 2023. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are received
on or before that date.
Comments received on or before
January 18, 2023, will be provided to
the committee. Comments received after
January 18, 2023, and by January 25,
2023, will be taken into consideration
by FDA. In the event that the meeting
is canceled, FDA will continue to
evaluate any relevant applications or
information, and consider any
comments submitted to the docket, as
appropriate.
You may submit comments as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
E:\FR\FM\19DEN1.SGM
19DEN1
Agencies
[Federal Register Volume 87, Number 242 (Monday, December 19, 2022)]
[Notices]
[Pages 77615-77617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27465]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3429-FN]
Medicare and Medicaid Programs: Application From the Center for
Improvement in Healthcare Quality for Continued Approval of Its
Hospital Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces our decision to approve the Center for
Improvement in Healthcare Quality (CIHQ) for continued recognition as a
national accrediting organization for hospitals that wish to
participate in the Medicare or Medicaid programs.
DATES: The decision announced in this notice is applicable January 1,
2023 through January 1, 2028.
FOR FURTHER INFORMATION CONTACT:
Erin Imhoff, (410) 786-2337.
Caecilia Blondiaux, (410) 786-2190.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from a hospital, provided certain requirements are
met. Section 1861(e) of the Social Security Act (the Act) establishes
statutory authority for the Secretary of the Department of Health and
Human Services (Secretary) to set distinct criteria for facilities
seeking designation as a hospital. Regulations concerning provider
agreements are at 42 CFR part 489 and those pertaining to activities
relating to the survey and certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part 482 specify the minimum
conditions of participation that a hospital must meet to participate in
the Medicare program.
Generally, to enter into an agreement, a hospital must first be
certified by a state survey agency (SA) as complying with the
conditions or requirements set forth in part 482 of our regulations.
Thereafter, the hospital is subject to regular surveys by a SA to
determine whether it continues to meet these requirements.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by a Centers for Medicare & Medicaid
Services (CMS) approved national accrediting organization (AO) that all
applicable Medicare requirements are met or exceeded, we will deem
those provider entities as having met such requirements. Accreditation
by an AO is voluntary and is not required for Medicare participation.
If an AO is recognized by the Secretary of the Department of Health
and Human Services (the Secretary) as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
would be deemed to meet the Medicare requirements. A national AO
applying for approval of its accreditation program under part 488,
subpart A, must provide CMS with reasonable assurance that the AO
requires the accredited provider entities to meet requirements that are
at least as stringent as the Medicare requirements. Our regulations
concerning the approval of AOs are set forth at Sec. Sec. 488.4, 488.5
and 488.5(e)(2)(i). The regulations at Sec. 488.5(e)(2)(i) require AOs
to reapply for continued approval of its accreditation program every 6
years or sooner, as determined by CMS.
[[Page 77616]]
Center for Improvement in Healthcare Quality (CIHQ)'s current term
of approval for their hospital accreditation program expires July 26,
2023. As discussed in the proposed notice (87 FR 43525), CIHQ submitted
its application for renewal earlier than expected and therefore CMS
will adjust their future term of approval accordingly.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS approval of an
accreditation program is conducted in a timely manner. The Act provides
us 210 days after the date of receipt of a complete application, with
any documentation necessary to make the determination to complete our
survey activities and application process. Within 60 days after
receiving a complete application, we must publish a notice in the
Federal Register that identifies the national accrediting body making
the request, describes the request, and provides no less than a 30-day
public comment period. At the end of the 210-day period, we must
publish a notice in the Federal Register approving or denying the
application.
III. Provisions of the Proposed Notice
On July 21, 2022, we published a proposed notice in the Federal
Register (87 FR 43525), announcing CIHQ's request for continued
approval of its Medicare hospital accreditation program. In that
proposed notice, we detailed our evaluation criteria. Under section
1865(a)(2) of the Act and in our regulations at Sec. Sec. 488.5 and
488.8(h), we conducted a review of CIHQ's Medicare hospital
accreditation application in accordance with the criteria specified by
our regulations, which include, but are not limited to the following:
An administrative review of CIHQ's: (1) corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its CIHQ facility surveyors; (4) ability to investigate
and respond appropriately to complaints against accredited CIHQ
facilities; and (5) survey review and decision-making process for
accreditation.
A review of CIHQ's survey processes to confirm that a
provider or supplier, under CIHQ's hospital deeming accreditation
program, meets or exceeds the Medicare program requirements.
A documentation review of CIHQ's survey process to do the
following:
++ Determine the composition of the survey team, surveyor
qualifications, and CIHQ's ability to provide continuing surveyor
training.
++ Compare CIHQ's processes to those we require of state survey
agencies, including periodic resurvey and the ability to investigate
and respond appropriately to complaints against CIHQ accredited
hospitals.
++ Evaluate CIHQ's procedures for monitoring accredited hospitals
it has found to be out of compliance with its program requirements.
++ Assess CIHQ's ability to report deficiencies to the surveyed
hospitals and respond to the hospitals plan of correction in a timely
manner.
++ Determine the adequacy of CIHQ's staff and other resources.
++ Confirm CIHQ's ability to provide adequate funding for
performing required surveys.
++ Confirm CIHQ's policies with respect to surveys being
unannounced.
++ Confirm CIHQ's policies and procedures to avoid conflicts of
interest, including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ Obtain CIHQ's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
IV. Analysis of and Responses to Public Comments on the Proposed Notice
In accordance with section 1865(a)(3)(A) of the Act, the July 21,
2022 proposed notice also solicited public comments regarding whether
CIHQ's requirements met or exceeded the Medicare conditions of
participation for hospitals. We received approximately 19 timely public
comments from hospitals and individuals, and another that was out of
scope of the proposed rule.
Comment: Most commenters expressed support for CIHQ and their
hospital accreditation program and encouraged CMS to approve them for
continued recognition as a national AO for hospitals.
Response: We appreciate the support from those hospitals who have
experience with CIHQ's Medicare hospital accreditation program and
agree that CIHQ should be approved for continued recognition as a
national AO for hospitals that wish to participate in the Medicare or
Medicaid programs.
Comment: A commenter expressed concern about hospital accreditation
programs overall and the responsibility of CMS to oversee the process.
The comment was not specific to CIHQ.
Response: We appreciate this comment and the concern for patient
safety and quality of care. We continue to prioritize patient safety
and our responsibility for oversight of AOs. As described in section
III. Provisions of the Proposed Notice of this notice, CMS takes
various steps when considering whether to approve or not approve a
national AO. Each AO wishing to be recognized by Medicare as a national
AO must go through a rigorous process for CMS approval. We remain
steadfast in our commitment to keeping the public informed of our
evaluation process for AOs seeking approval from CMS.
Comment: A commenter expressed concern for paying out of pocket for
chronic diseases.
Response: We thank the commenter for expressing concern, but this
comment is outside the scope of the notice.
Final Decision: After consideration of the public comments
received, we are finalizing our decision to approve CIHQ's application
for continued recognition as a national AO for hospitals that wish to
participate in the Medicare or Medicaid programs.
V. Provisions of the Final Notice
A. Differences Between CIHQ's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared CIHQ's hospital accreditation requirements and survey
process with the Medicare conditions of participation of part 482, and
the survey and certification process requirements of parts 488 and 489.
Our review and evaluation of CIHQ's renewal application, which were
conducted as described in section III. of this final notice, yielded
the following areas where, as of the date of this notice, CIHQ has
completed revising its standards and certification processes in order
to--
Meet the requirements of all of the following Medicare
regulations:
++ Section 482.41(a)(1), to include the appropriate Life Safety
Code (LSC) references that address hospitals classified as new
occupancies.
++ Section 482.41(b)(1)(i), to include the appropriate National
Fire Protection Agency (NFPA) 101 requirements for hospitals classified
as Business Occupancies.
++ Section 482.41(d)(4), to include compliance with the 2008
American Society of Heating, Refrigerating and Air-Conditioning
Engineers (ASHRAE) Standard 170--Ventilation of Health Care Facilities,
in accordance with 2012
[[Page 77617]]
NFPA requirements and to ensure sterile supply and medical equipment
manufacturer instructions for use (IFUs) are considered before
hospitals reduce relative humidity levels.
++ Section 488.5(a)(3), to correct formatting and technical errors
in the crosswalk as requested by CMS.
In addition to the standards review, CMS reviewed CIHQ's comparable
survey processes, which was conducted as described in section III. of
this notice, and also reviewed corporate policies, which yielded the
following areas where, as of the date of this notice, CIHQ has
completed revising its survey processes to demonstrate that it uses
survey processes that are comparable to state survey agency processes
by:
++ Revising Facility & Life Safety worksheets for surveyors to
explain that the worksheet does not include all 2012 LSC & Health Care
Facilities Code requirements in accordance with survey comparability at
Sec. 488.5(a)(4)(ii).
++ Providing additional training to surveyors related to the number
of medical records that should be reviewed during the survey of larger
hospitals in accordance with survey comparability at Sec.
488.5(a)(4)(ii).
++ Improving the level of detail in survey documentation in
accordance with survey comparability at Sec. 488.5(a)(4)(ii).
++ Providing CMS with the job description required for CIHQ's LSC
Consultants in accordance with the description of education and
experience requirements surveyors must meet at Sec. 488.5(a)(7).
++ Revising complaint procedures to ensure the survey investigation
process is clearly documented in accordance with the organizations
complaint procedures at Sec. 488.5(a)(12).
B. Term of Approval
Based on our review and observations described in section III. and
section V. of this notice, we approve CIHQ as a national accreditation
organization for hospitals that request participation in the Medicare
program. The decision announced in this notice is effective January 1,
2023 through January 1, 2028 (5 years). Due to the timing of the start
of the fiscal year and associated travel restrictions, CMS was unable
to conduct a hospital survey observation of CIHQ surveyors in
accordance with 42 CFR 488.8(h), which is one component of the
comparability evaluation. Therefore, we are providing CIHQ with a
reduced term of approval. In accordance with 42 CFR 488.5(e)(2)(i), CMS
may not give a term of the approval that exceeds 6 years.
Based on our discussions with CIHQ and the information provided in
its application, we are confident that CIHQ will continue to ensure
that its deemed hospitals will continue to meet or exceed Medicare
standards. Additionally, CIHQ has applied for critical access hospital
deeming authority and as part of that application we will complete a
survey observation. Critical access hospitals have similar CoPs and
survey process to hospitals and therefore we are confident in a 5-year
approval term for this application.
VI. Collection of Information and Regulatory Impact Statement
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: December 14, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2022-27465 Filed 12-16-22; 8:45 am]
BILLING CODE 4120-01-P